Discover Tenders by Non Directional Beacon Ndb Sector

Find the most relevant tenders for Non Directional Beacon Ndb. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Non Directional Beacon Ndb tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Non Directional Beacon Ndb tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Edoxaban B01Af03 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8804405

EMD:Ref Document

Bid Value: Ref Document

311 Days Left

Open House Drug Rebate Agreements Lopinavir And Ritonavir Atc J05Ar10

Deadline: 05 Sep 2026

Germany

Ref. No.: 8804354

EMD:Ref Document

Bid Value: Ref Document

316 Days Left

Open House Drug Rebate Agreements Denosumab Atc M05Bx04

Deadline: 05 Sep 2026

Germany

Ref. No.: 8804091

EMD:Ref Document

Bid Value: Ref Document

316 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Bosutinib L01Ea04 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8803968

EMD:Ref Document

Bid Value: Ref Document

311 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Timolol Brinzolamide Atc S01Ed67 Obg For The Period 01 11 2024 31 10 2026

Deadline: 05 Sep 2026

Germany

Ref. No.: 8801281

EMD:Ref Document

Bid Value: Ref Document

316 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Allergen Extract Of Various Origins Subcutaneous Syringes V01Aa02 V01Aa03 V01Aa05 For The Period 01 11 2024 31 10 2026

Deadline: 05 Sep 2026

Germany

Ref. No.: 8800167

EMD:Ref Document

Bid Value: Ref Document

316 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Interferon Beta 1A Exclusively For Subcutaneous Use Atc L03Ab07 For The Period 01 11 2024 31 10 2026

Deadline: 05 Sep 2026

Germany

Ref. No.: 8798282

EMD:Ref Document

Bid Value: Ref Document

316 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Filgotinib L04Af04 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8796348

EMD:Ref Document

Bid Value: Ref Document

311 Days Left

Open House Drug Rebate Agreements Sorafenib Atc L01Ex02

Deadline: 05 Sep 2026

Germany

Ref. No.: 8793928

EMD:Ref Document

Bid Value: Ref Document

316 Days Left

Open House Drug Discount Agreements Naproxen Atc M01Ae02

Deadline: 05 Sep 2026

Germany

Ref. No.: 8793766

EMD:Ref Document

Bid Value: Ref Document

316 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Filgrastim L03Aa02 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8791885

EMD:Ref Document

Bid Value: Ref Document

311 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Golimumab L04Ab06 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8791055

EMD:Ref Document

Bid Value: Ref Document

311 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Ciclosporin S01Xa18

Deadline: 10 Aug 2026

Germany

Ref. No.: 8790550

EMD:Ref Document

Bid Value: Ref Document

290 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Erythropoietin B03Xa01 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8789001

EMD:Ref Document

Bid Value: Ref Document

311 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Olanzapine N05Ah03 Without Solid Oral Dosage Forms As Part Of A So Called Open Hou

Deadline: 31 Aug 2026

Germany

Ref. No.: 8788988

EMD:Ref Document

Bid Value: Ref Document

311 Days Left

Showing 28156 to 28170 of 29005 results

‹
1
2
...
1875
1876
1877
1878
1879
1880
1881
...
1933
1934
›

Discover Tenders by Non Directional Beacon Ndb Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Non Directional Beacon Ndb Sector

Filter Your Search

FREE Trial plan for all new users!